CI · Cigna Group · Documents

Mar 17

Proxy statement DEF 14A

Proxy statement

Mar 17

Annual report to holders ARS

Annual report to holders

Mar 17

Proxy statement DEFA14A

Proxy statement

Mar 7

Current report 8-K

Entered into a material agreement, New debt or off-balance-sheet obligation, Regulation FD disclosure, Other events

Mar 6

Proxy statement PRE 14A

Proxy statement

Feb 27

Current report 8-K

Regulation FD disclosure

Feb 23

Annual report 10-K FY2022, ended Dec 31

Annual report for FY2022

Revenue $180.52B ▲ 3.7% Net income $6.75B ▲ 24.6% Diluted EPS $21.30 ▲ 35.4%

Feb 13

Current report 8-K

Charter or bylaw amendment, or fiscal year change

Feb 3

Current report 8-K

Financial results

Feb 3

Earnings call

Q4 2022 earnings call

Dec 30

Current report 8-K

Regulation FD disclosure

Dec 1

Registration statement S-3ASR

Registration statement

Nov 30

Current report 8-K

Regulation FD disclosure

Nov 3

Current report 8-K

Financial results

Nov 3

Quarterly report 10-Q FY2022 Q3, ended Sep 30

Quarterly report for FY2022 Q3

Revenue $45.28B ▲ 2.2% Net income $2.78B ▲ 69.9% Diluted EPS $8.97 ▲ 86.9%

Nov 3

Earnings call

Q3 2022 earnings call

Oct 28

Current report 8-K Events of Oct 26

Charter or bylaw amendment, or fiscal year change

Sep 13

Current report 8-K

Regulation FD disclosure

Aug 4

Current report 8-K

Financial results

Aug 4

Quarterly report 10-Q FY2022 Q2, ended Jun 30

Quarterly report for FY2022 Q2

Revenue $45.48B ▲ 5.4% Net income $1.57B ▲ 6.5% Diluted EPS $4.90 ▲ 15.3%

Aug 4

Earnings call

Q2 2022 earnings call

Jun 16

Current report 8-K Events of Jun 15

Other events

Jun 3

Current report 8-K

Regulation FD disclosure

May 9

Current report 8-K/A Events of May 6

Financial results

May 6

Current report 8-K

Financial results

May 6

Quarterly report 10-Q FY2022 Q1, ended Mar 31

Quarterly report for FY2022 Q1

Revenue $44.01B ▲ 7.4% Net income $1.2B ▲ 2.3% Diluted EPS $3.68 ▲ 11.5%

May 6

Earnings call

Q1 2022 earnings call

May 2

Current report 8-K Events of Apr 27

Shareholder vote results

Apr 29

Current report 8-K Events of Apr 28

Entered into a material agreement, New debt or off-balance-sheet obligation, Other events

Apr 14

Proxy statement DEFA14A

Proxy statement

Apr 5

Proxy statement DEFA14A

Proxy statement

Mar 18

Proxy statement DEF 14A Meeting Apr 27, 2022

Proxy statement

Mar 18

Proxy statement DEFA14A

Proxy statement

Feb 24

Current report 8-K

Regulation FD disclosure

Feb 24

Annual report 10-K FY2021, ended Dec 31

Annual report for FY2021

Revenue $174.08B ▲ 8.5% Net income $5.42B ▼ 36.2% Diluted EPS $15.73 ▼ 31.5%

Feb 3

Earnings call

Q4 2021 earnings call

Feb 3

Current report 8-K

Financial results

Jan 24

Current report 8-K

Regulation FD disclosure

Dec 27

Current report 8-K

Regulation FD disclosure

Dec 8

Current report 8-K Events of Dec 2

Charter or bylaw amendment, or fiscal year change

Nov 29

Current report 8-K

Regulation FD disclosure

Nov 4

Earnings call

Q3 2021 earnings call

Nov 4

Current report 8-K

Financial results

Nov 4

Quarterly report 10-Q FY2021 Q3, ended Sep 30

Quarterly report for FY2021 Q3

Revenue $44.29B ▲ 8.1% Net income $1.64B ▲ 17.0% Diluted EPS $4.80 ▲ 27.0%

Sep 23

Current report 8-K Events of Sep 20

Director or officer change, or executive pay, Regulation FD disclosure

Sep 2

Current report 8-K

Regulation FD disclosure

Aug 5

Earnings call

Q2 2021 earnings call

Aug 5

Current report 8-K

Financial results

Aug 5

Quarterly report 10-Q FY2021 Q2, ended Jun 30

Quarterly report for FY2021 Q2

Revenue $43.13B ▲ 9.8% Net income $1.48B ▼ 16.1% Diluted EPS $4.25 ▼ 10.1%

Jul 30

Current report 8-K Events of Jul 26

Director or officer change, or executive pay, Other events